Description
RICLOP-A Tablet contains Clopidogrel 75mg and Aspirin 75mg, a combination of two antiplatelet medicines that reduce platelet aggregation through different mechanisms. It may be prescribed to eligible patients with selected cardiovascular conditions, including acute coronary syndrome or following certain coronary procedures, to help reduce the risk of atherothrombotic events.
Clopidogrel inhibits the platelet P2Y12 ADP receptor, while aspirin reduces platelet thromboxane A2 production by inhibiting cyclooxygenase-1 (COX-1). Their complementary actions can help reduce platelet-rich clot formation when dual antiplatelet therapy is clinically indicated. However, the combination also increases bleeding risk and is not appropriate for every patient.
CardianCare focuses on cardiac and diabetic healthcare products for doctors, pharmacists, distributors and pharmaceutical business partners. Businesses searching for a Clopidogrel 75 mg + Aspirin 75 mg Tablets manufacturer India can enquire about product availability, approved specifications, manufacturing-source information and applicable quality documentation.
For pharmaceutical procurement teams evaluating a Clopidogrel 75mg and Aspirin 75mg Tablets manufacturer and supplier India, important considerations include composition accuracy, product authorization, batch traceability, packaging, shelf life and commercial supply terms.
2. Key Ingredients
Composition: Clopidogrel 75mg and Aspirin 75mg
Confirm the stated strengths and approved dosage form against the product packaging and official product documentation.
Clopidogrel 75 mg
Clopidogrel is an antiplatelet medicine that inhibits the platelet P2Y12 ADP receptor after meTabletolic activation. This reduces platelet activation and aggregation, helping limit platelet-rich clot formation in patients for whom antiplatelet therapy is indicated.
Aspirin 75 mg
Low-dose aspirin inhibits platelet cyclooxygenase-1 (COX-1), reducing the production of thromboxane A2, a substance involved in platelet activation. This reduces platelet aggregation through a pathway different from clopidogrel.
Together, these ingredients provide dual antiplatelet action. The potential benefit must be weighed against the increased risk of bleeding, with treatment and duration determined by the prescribing clinician.
Businesses researching a Clopidogrel 75mg and Aspirin 75mg pharmaceutical company India should review product authorization, approved labelling, composition specifications and applicable quality documentation before procurement.
Companies evaluating a Clopidogrel 75mg and Aspirin 75mg medicine manufacturer India should verify the legal manufacturer, regulatory status, batch documentation and relevant quality standards before entering a supply arrangement.
3. Key Benefits
Dual antiplatelet action: Clopidogrel and aspirin reduce platelet aggregation through different biological pathways.
Cardiovascular risk management: May help reduce the risk of certain atherothrombotic events in appropriately selected patients.
Complementary mechanisms: Combines P2Y12 receptor inhibition with COX-1 inhibition when dual antiplatelet therapy is indicated.
Oral treatment option: Provides a Tablet-based formulation for patients prescribed this combination.
Role in selected cardiovascular care: May be used in treatment plans following certain coronary events or procedures, according to clinical guidance.
Individualized treatment support: Can form part of a broader cardiovascular management plan that includes follow-up, risk-factor control and other prescribed treatments.
The combination is not automatically suitable for all patients with cardiovascular disease. Treatment decisions depend on the indication, bleeding risk, medical history, other medicines and the recommended duration of dual antiplatelet therapy.
Pharmaceutical buyers searching for a Clopidogrel 75 mg + Aspirin 75 mg supplier India should verify product authenticity, availability, shelf life, storage conditions and supporting documentation.
A Clopidogrel 75mg and Aspirin 75mg Tablet wholesaler and distributor India enquiry may include stock availability, minimum order quantities, delivery coverage, licensing requirements and applicable commercial terms.
Businesses seeking a Clopidogrel 75mg and Aspirin 75mg bulk supplier India should request a formal quotation and confirm batch traceability, packaging specifications, storage requirements and quality documentation.
A Clopidogrel 75mg and Aspirin 75mg pharmaceutical distributor India should verify product authorization, distribution eligibility and approved promotional information before beginning commercial activities.
4. How Does It Work?
Clopidogrel mechanism
Clopidogrel is converted in the body into an active meTabletolite that irreversibly inhibits the platelet P2Y12 ADP receptor. This reduces ADP-mediated platelet activation and aggregation.
Aspirin mechanism
Aspirin irreversibly inhibits platelet COX-1, reducing thromboxane A2 production. This decreases platelet aggregation through a mechanism separate from clopidogrel’s action.
Combined action
The two medicines inhibit platelet function through complementary pathways, helping reduce the tendency for platelets to form harmful clots when dual antiplatelet therapy is clinically appropriate.
Because both medicines affect platelet function, bleeding may occur more easily or last longer. The prescriber must assess the balance between cardiovascular benefit and bleeding risk and determine the appropriate treatment duration.
5. Directions for Use
Dosage: Take only as prescribed by a qualified doctor. The appropriate regimen depends on the clinical indication and individual medical history.
Administration: Follow the approved product label and prescriber’s instructions for the exact dosage form.
Food instructions: Follow the product-specific instructions supplied with the medicine.
Regular timing: Follow the prescribed schedule consistently. Do not change the dose or frequency independently.
Missed dose: Follow the patient information leaflet or ask a doctor or pharmacist. Do not take a double dose to compensate for a missed dose.
Treatment continuity: Do not stop either antiplatelet medicine without medical advice, particularly after a coronary event or stent procedure.
Before surgery or dental procedures: Inform the surgeon or dentist about this treatment. Any decision to interrupt it must be made by the responsible clinician.
Monitoring: Attend recommended follow-up appointments and report unusual bruising, persistent bleeding or other concerning symptoms.
The appropriate regimen and treatment duration depend on the patient’s diagnosis, previous cardiovascular events or procedures, bleeding risk and other medicines.
6. Possible Side Effects
Possible side effects include:
Indigestion or abdominal discomfort
Nausea
Easy bruising
Nosebleeds
Prolonged bleeding from minor cuts
Gastrointestinal irritation
Important adverse reactions
Serious bleeding: Vomiting blood, black or tarry stools, blood in urine, uncontrolled bleeding or a sudden severe headache requires urgent medical assessment.
Gastrointestinal ulcers: Aspirin can irritate the stomach and increase the risk of ulcers and gastrointestinal bleeding.
Allergic reactions: Facial or throat swelling, difficulty breathing or a severe rash requires emergency care.
Rare blood disorders: Clopidogrel has rarely been associated with serious blood disorders, including thrombotic thrombocytopenic purpura (TTP). Unexplained fever, unusual bruising, marked weakness or neurological symptoms require urgent medical assessment.
This list is not exhaustive. Seek professional medical advice about persistent or concerning symptoms.
7. Safety Information
Medical supervision: Use only under the guidance of a qualified healthcare professional.
Bleeding risk: The combination increases bleeding risk. Inform the doctor about previous gastrointestinal bleeding, ulcers, bleeding disorders or unexplained bruising.
Contraindications: This combination is generally contraindicated in active pathological bleeding and serious hypersensitivity to either ingredient. Follow the approved product information for specific contraindications.
Aspirin sensitivity: Tell the prescriber about aspirin allergy, previous reactions to NSAIDs or aspirin-sensitive asthma.
Stroke history: Patients with previous intracranial bleeding or certain types of stroke require careful medical assessment before treatment.
Surgery and procedures: Inform all treating healthcare professionals about this medicine before surgery, dental work or invasive procedures. Do not discontinue it independently.
Liver health: Inform the doctor about liver disease or a history of bleeding associated with liver problems.
Kidney health: Tell the prescriber about kidney impairment and follow any recommended monitoring.
Pregnancy: Seek medical advice before use during pregnancy or when planning pregnancy. Aspirin and clopidogrel require indication-specific assessment.
Breastfeeding: Consult a healthcare professional before use while breastfeeding.
Drug interactions: Inform the doctor about all prescription medicines, over-the-counter products and supplements. Anticoagulants, other antiplatelet medicines and NSAIDs can increase bleeding risk. Some medicines, including certain acid-reducing medicines, can also affect clopidogrel activation.
Storage: Store in the original packaging according to the approved product label, protected from excessive heat and moisture and out of children’s reach.
This information is educational and does not replace approved prescribing information or individualized medical advice.
8. B2B Pharmaceutical Business Enquiries
CardianCare focuses on cardiac and diabetic healthcare products and provides a contact point for pharmaceutical trade enquiries. Doctors, pharmacists, procurement teams, wholesalers, distributors and eligible business partners can contact the company to enquire about current product availability and applicable commercial arrangements.
Businesses researching a Clopidogrel 75mg and Aspirin 75mg PCD pharma franchise India opportunity should confirm directly whether the product and the relevant programme are available, including territory eligibility, partner requirements and applicable commercial terms.
For a Clopidogrel 75mg and Aspirin 75mg Tablets PCD pharma franchise enquiry, prospective partners may request details about product availability, minimum order quantities, licensing requirements, distribution eligibility and any applicable promotional support.
Companies exploring a Clopidogrel 75mg and Aspirin 75mg Tablet PCD franchise should verify the current programme and product availability before making investment or promotional commitments.
Businesses evaluating Clopidogrel 75mg and Aspirin 75mg third party manufacturing India services should first confirm whether the proposed company offers these arrangements. Due diligence should cover manufacturing authorization, applicable GMP compliance, product approvals, quality documentation and batch-release procedures.
A Clopidogrel 75mg and Aspirin 75mg Tablet third party manufacturer India enquiry should cover manufacturing-facility credentials, approved specifications, quality systems, packaging requirements, regulatory responsibilities and product traceability.
Companies investigating Clopidogrel 75mg and Aspirin 75mg contract manufacturing India should confirm service availability and discuss technical specifications, quality agreements, product authorization, regulatory responsibilities and commercial feasibility with the proposed manufacturing partner.
Contact CardianCare through its official website to enquire about current product availability, pharmaceutical distribution opportunities and applicable business arrangements. PCD franchise, third-party manufacturing and contract manufacturing services must be confirmed directly before being represented as available.
9. For More Information
For more information about RICLOP-A Tablet (Clopidogrel 75 mg + Aspirin 75 mg), click here













Reviews
There are no reviews yet.